Doses (mGy/MBq) from Combined Sources (Injected Breast + Total Body) to 6-Month-Pregnant Models
| Organ | Reference model | MSKCC model | MSKCC childbearing model |
|---|---|---|---|
| Adrenals | 1.94E−03 | 1.76E−03 | 1.83E−03 |
| Brain | 1.46E−04 | 1.31E−04 | 1.36E−04 |
| Injected breast | 8.04E−01 | 2.97E−01 | 4.04E−01 |
| Gallbladder wall | 1.59E−03 | 1.44E−03 | 1.49E−03 |
| LLI wall | 4.12E−04 | 3.74E−04 | 3.88E−04 |
| Small intestine | 6.08E−04 | 5.49E−04 | 5.71E−04 |
| Stomach wall | 3.19E−03 | 2.88E−03 | 2.99E−03 |
| ULI wall | 1.63E−03 | 1.47E−03 | 1.53E−03 |
| Heart wall | 1.16E−02 | 1.05E−02 | 1.09E−02 |
| Kidneys | 8.27E−04 | 7.49E−04 | 7.76E−04 |
| Liver | 3.35E−03 | 3.03E−03 | 3.15E−03 |
| Lungs | 8.17E−03 | 7.40E−03 | 7.68E−03 |
| Muscle | 1.75E−03 | 1.58E−03 | 1.64E−03 |
| Ovaries | 1.95E−04 | 1.77E−04 | 1.83E−04 |
| Pancreas | 2.41E−03 | 2.18E−03 | 2.26E−03 |
| Red marrow | 1.90E−03 | 1.71E−03 | 1.78E−03 |
| Osteogenic cells | 3.10E−03 | 2.80E−03 | 2.91E−03 |
| Skin | 2.92E−03 | 2.65E−03 | 2.75E−03 |
| Spleen | 1.67E−03 | 1.51E−03 | 1.56E−03 |
| Thymus | 8.83E−03 | 8.00E−03 | 8.29E−03 |
| Thyroid | 1.27E−03 | 1.15E−03 | 1.19E−03 |
| Bladder wall | 1.34E−04 | 1.21E−04 | 1.26E−04 |
| Uterus | 6.86E−04 | 6.20E−04 | 6.44E−04 |
| Fetus | 6.18E−04 | 5.59E−04 | 5.81E−04 |
| Placenta | 1.30E−03 | 1.18E−03 | 1.22E−03 |
| Total body | 3.99E−03 | 3.56E−03 | 3.71E−03 |
| Effective dose (mSv/MBq) | 2.49E−02 | 1.01E−02 | 1.32E−02 |